Fox Run Management’s TG Therapeutics TGTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $354K | Sell |
9,832
-9,171
| -48% | -$330K | 0.06% | 596 |
|
|
2025
Q1 | $749K | Buy |
+19,003
| New | +$749K | 0.12% | 307 |
|
|
2024
Q2 | – | Sell |
-50,724
| Closed | -$772K | – | 1077 |
|
|
2024
Q1 | $772K | Buy |
50,724
+23,061
| +83% | +$351K | 0.17% | 224 |
|
|
2023
Q4 | $472K | Buy |
27,663
+11,884
| +75% | +$203K | 0.12% | 329 |
|
|
2023
Q3 | $132K | Buy |
+15,779
| New | +$132K | 0.04% | 607 |
|
|
2023
Q2 | – | Sell |
-25,736
| Closed | -$387K | – | 956 |
|
|
2023
Q1 | $387K | Buy |
+25,736
| New | +$387K | 0.13% | 316 |
|
|
2018
Q2 | – | Sell |
-16,738
| Closed | -$238K | – | 911 |
|
|
2018
Q1 | $238K | Buy |
+16,738
| New | +$238K | 0.06% | 575 |
|
|
2017
Q3 | – | Sell |
-15,500
| Closed | -$156K | – | 860 |
|
|
2017
Q2 | $156K | Buy |
+15,500
| New | +$156K | 0.05% | 570 |
|
|
2017
Q1 | – | Sell |
-18,600
| Closed | -$86K | – | 745 |
|
|
2016
Q4 | $86K | Buy |
+18,600
| New | +$86K | 0.05% | 473 |
|